Becton, Dickinson and Co. | BDX - هزینه بهره بدهی

قیمت سهام
152.14
تغییر روزانه
-2.71 -1.75%
ماهیانه
-3.87%
سالیانه
-25.81%
Q2 پیش بینی
148.88




هزینه بهره بدهی تغییر دادن تاریخ
Abbott USD 68M 26M 2026-03
Agilent USD 25M 2M 2025-12
Align Technology USD 2M 660K 2023-03
AngioDynamics USD 102K 2K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 22M 1000K 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12